Legal & General Group PLC Atai Life Sciences N.V. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$1.04 - $1.55 $45,120 - $67,246	-43,385 Reduced 71.88%	16,975 $23,000
Q3 2023 Nov 14, 2023	SELL	$1.27 - $2.28 $39,094 - $70,185	-30,783 Reduced 33.77%	60,360 $77,000
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.19 $122,420 - $186,180	85,014 Added 1387.08%	91,143 $156,000
Q1 2023 May 15, 2023	SELL	$1.17 - $2.7 $30,135 - $69,543	-25,757 Reduced 80.78%	6,129 $11,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $100,122 - $155,284	31,886 New	31,886 $105,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.